Breaking News
Get 40% Off 0
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now
Close

Aarti Drugs Ltd (ADRG)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
499.10 -5.45    -1.08%
05:59:58 - Closed. Currency in INR ( Disclaimer )
Type:  Equity
Market:  India
ISIN:  INE767A01016 
S/N:  AARTIDRUGS
  • Volume: 62,003
  • Bid/Ask: 499.10 / 500.80
  • Day's Range: 499.00 - 508.95
Aarti Drugs Ltd 499.10 -5.45 -1.08%

NS:ADRG Financials

 
A brief overview of the NS:ADRG financials. This summary provides an overview of the most significant critical numbers from each of its financial reports, including the income statement, balance sheet, and cash flow statement. Additionally, it features several financial ratios that provide insight into the company's financial health. Users can select to view data from four periods of either annual or quarterly information, allowing them to track financial performance of Aarti Drugs Ltd over time.

Aarti Drugs Limited reported earnings results for the second quarter and six months ended September 30, 2023. For the second quarter, the company reported sales was INR 6,415.4 million compared to INR 6,877.2 million a year ago. Revenue was INR 6,422.2 million compared to INR 6,877.8 million a year ago. Net income was INR 395.9 million compared to INR 387.5 million a year ago. Basic earnings per share from continuing operations was INR 4.29 compared to INR 4.18 a year ago. Diluted earnings per share from continuing operations was INR 4.29 compared to INR 4.18 a year ago.For the six months, sales was INR 13,026.4 million compared to INR 13,096.8 million a year ago. Revenue was INR 13,039.3 million compared to INR 13,100 million a year ago. Net income was INR 874.4 million compared to INR 735.4 million a year ago. Basic earnings per share from continuing operations was INR 9.47 compared to INR 7.94 a year ago. Diluted earnings per share from continuing operations was INR 9.47 compared to INR 7.94 a year ago.

AnnualQuarterly  
InvestingPro Advanced Financial Summary
TTM = Trailing Twelve Months
MRQ = Most Recent Quarter

ADRG Income Statement

Gross margin TTM 31.43%
Operating margin TTM 10.45%
Net Profit margin TTM 6.8%
Return on Investment TTM 11.73%
 Total Revenue  Net Income
Period Ending: Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023
Total Revenue 6059.4 6415.3 6611.1 7424.04
Gross Profit 2007 2125 2147.6 2051.5
Operating Income 591.4 645.2 720.7 812.14
Net Income 366.7 395.9 479.7 560.89

ADRG Balance Sheet

Quick Ratio MRQ 0.87
Current Ratio MRQ -
LT Debt to Equity MRQ 17.54%
Total Debt to Equity MRQ 48.71%
 Total Assets  Total Liabilities
Period Ending: Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023
Total Assets 23518.3 24213.98
Total Liabilities 11420.26 12287.3
Total Equity 12098.04 12098.04 11926.63 11926.68

ADRG Cash Flow Statement

Cash Flow/Share TTM 34.49
Revenue/Share TTM 288.36
Operating Cash Flow  -
 Cash  Net Change in Cash
Period Ending: Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023
Period Length: 0 Months 0 Months 0 Months 0 Months
Cash From Operating Activities
Cash From Investing Activities
Cash From Financing Activities
Net Change in Cash
* In Millions of INR (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

ADRG Comments

Write your thoughts about Aarti Drugs Ltd
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Lovely Trader
Lovely Trader Jul 06, 2021 8:52AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
be ready for healthy correction.
Lovely Trader
Lovely Trader Jul 04, 2021 4:20PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
it will swing between 713 to 743 if it cross then we can see 780 levels in July.
Umesh Goswami
Umesh Goswami Jun 29, 2021 1:51AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Buy bandhan bank at 340 shrot term target 400++
Siddhesh Ghadigaonkar
Siddhesh Ghadigaonkar May 28, 2021 1:28PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Guys buy Aarti Drugs now for the target of 10000
Karan Sharma
Karan Sharma Apr 11, 2021 4:14AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
now buy time of aarti drug guys just do buy
chef vinay singh
chef vinay singh Apr 08, 2021 4:55AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
buy aarti drugs
monica shah
monica shah Mar 20, 2021 1:01PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
should I buy Aarti drugs
Mar 20, 2021 1:01PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
wht its target
monica shah
monica shah Mar 20, 2021 1:01PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
should I buy Aarti drugs
ranajit bhattacharyya
ranajit bhattacharyya Dec 23, 2020 1:27AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
What is happening here ?
SJS Badwal
SJS Badwal Nov 02, 2020 12:45AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
What has gone wrong with Arti Drugs
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email